Super Micro Computer (NASDAQ: SMCI) is trading at its lowest forward earnings multiple in roughly 18 months, below 10x fiscal 2027 estimates, yet the same period that compressed that valuation also exposed structural margin problems that make the discount less compelling than it appears.
At a Glance
- Revenue is up more than 250% since early 2024; net profit has risen only ~70%, reflecting severe margin compression.
- SMCI now trades below 12x fiscal 2026 earnings and under 10x fiscal 2027 estimates on a forward basis.
- Current market cap sits at approximately $21 billion.
- A $7 billion equity raise announced this month will meaningfully dilute existing shareholders and weigh on EPS.
- Fraud allegations from 2024 were ultimately cleared, but reputational and financial damage to the stock persists.
Revenue Growth Masks a Deteriorating Margin Profile
The headline growth numbers look strong. Since January 2024, Supermicro's trailing revenue has climbed more than 250%, driven by surging enterprise demand for AI-optimized servers, liquid-cooled rack systems, and high-density compute infrastructure. That kind of top-line expansion would ordinarily justify a premium multiple.
Profit growth tells a different story. Over the same stretch, earnings rose only around 70% — a fraction of the revenue gain. The divergence points directly at pricing power, or the lack of it. Supermicro competes in a market where several vendors offer technically similar racking and server configurations. With limited differentiation at the product level, the segment has effectively commoditized, and Supermicro has been unable to hold margins as competition intensifies.
That dynamic is unlikely to reverse quickly. AI infrastructure spending remains strong, but so does the supply response. The gap between revenue growth and profit growth is a structural signal, not a temporary blip tied to any single quarter's cost overrun.

The $7 Billion Equity Raise Changes the EPS Math
Announced earlier this month, Supermicro's plan to sell $7 billion in new equity is the single most consequential near-term variable for shareholders. The raise is substantial relative to a market cap of roughly $21 billion — implying a dilution event on the order of one-third of the company's current equity value. Share counts will rise sharply, and every EPS estimate published before this announcement needs to be revised downward.
The stock sold off hard on the news. That reaction is rational. Even at sub-10x forward earnings, the denominator in that ratio is now a moving target, and until analysts have fully rebased their models to the post-dilution share count, the valuation may look cheaper on screens than it actually is on a per-share basis.
The capital raise also raises a strategic question: what does management intend to do with $7 billion? If it funds capacity expansion in a commoditizing market, returns on that capital may prove modest. If it's being raised partly to shore up the balance sheet following the turbulence of the past 18 months, that's a different kind of red flag.
The Fraud Saga: Cleared, but Not Forgotten
Supermicro's auditor resigned in 2024 amid fraud allegations that briefly made the company an existential risk story rather than a growth one. A replacement auditor was brought in, and the investigation ultimately cleared Supermicro's leadership of wrongdoing. Technically, the cloud lifted.
Practically, the damage is still visible in the stock chart. SMCI is trading only marginally above its January 2024 level despite the 250%-plus revenue growth recorded since then. The market has not rewarded that growth with multiple expansion. Part of that reflects the margin compression described above, but part reflects a persistent credibility discount that typically takes several quarters of clean, audited financials to fully dissolve.

Valuation: Cheap Versus Fairly Priced for the Risk
At below 10x fiscal 2027 earnings, SMCI screens as inexpensive against the broader technology sector and against AI-adjacent peers. The question is whether that multiple adequately compensates for the specific risks attached to this business.
| Metric | Current Reading |
|---|---|
| Forward P/E (FY2026) | <12x |
| Forward P/E (FY2027) | <10x |
| Market Cap | ~$21 billion |
| Revenue Growth Since Jan 2024 | >250% |
| Profit Growth Since Jan 2024 | ~70% |
Note that FY2026 ends this month, so the sub-12x figure is effectively a trailing-forward number. FY2027 estimates are the more relevant yardstick. Sub-10x is genuinely low for a company growing revenue at this pace — but only if margin stabilization materializes. If gross margins continue to compress, those earnings estimates will come down, and the multiple will expand even without any move in the share price.
The honest bear case here isn't that the stock is obviously expensive. It's that the earnings power is harder to forecast than the revenue line, and the $7 billion dilution event adds another variable that muddles near-term EPS visibility.
Supermicro vs. Upstream AI Exposure
Supermicro's business depends on the AI infrastructure build-out, but it sits at a disadvantage relative to companies that control more proprietary technology in that stack. Nvidia, for instance, sells the GPUs that Supermicro integrates into its servers. Nvidia's gross margins reflect that pricing power; Supermicro's margins reflect the absence of it.
For investors seeking AI exposure, the upstream question matters: is it better to own the pick-and-shovel supplier with commodity-level pricing, or the IP-intensive company whose products have no direct substitute? On a risk-adjusted basis, companies higher in the AI value chain with defensible margins warrant a higher allocation, even at premium multiples, compared to lower-margin integrators trading cheaply for legitimate structural reasons.
Frequently Asked Questions
Why is Supermicro's stock still near its January 2024 level despite massive revenue growth?
The market has priced in both the fraud-related credibility discount from 2024 and the margin deterioration that has kept profit growth far below revenue growth. A stock price reflects earnings power, not just top-line scale — and Supermicro's earnings haven't expanded proportionally.
What does the $7 billion equity raise mean for existing shareholders?
It represents significant dilution. With a market cap around $21 billion, raising $7 billion in new equity will substantially increase the share count, reducing earnings per share unless the proceeds generate returns that offset the dilution — and in a margin-compressed market, that's not a straightforward outcome.
Is a sub-10x forward P/E actually cheap for Supermicro?
It's low in absolute terms, but earnings estimates carry above-average uncertainty here due to ongoing margin pressure and the dilutive capital raise. If forward EPS estimates are revised down post-dilution, the real forward multiple may be higher than screens currently indicate.
Were Supermicro's executives actually found guilty of fraud?
No. After the company's auditor resigned and a new one was brought in, Supermicro's leadership was cleared of wrongdoing. The allegations did not result in confirmed fraud findings against the company's management.
Where the Stock Goes From Here
Supermicro's valuation is objectively low relative to its revenue trajectory, but the investment case depends almost entirely on whether margins stabilize — something the company hasn't demonstrated it can control in a competitive market. The $7 billion equity raise introduces a near-term EPS headwind that consensus estimates may not yet fully reflect. Until there's evidence that gross margin has found a floor, the discount looks justified rather than exploitable.



